Xcout Intel
Corteria Pharmaceuticals competitors & alternatives
The 12 closest competitors and alternatives to Corteria Pharmaceuticals among biotechnology companies — ranked by similarity to what Corteria Pharmaceuticals actually does, not by market-cap band.
Subscribe to see Corteria Pharmaceuticals’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Corteria Pharmaceuticals
Corteria Pharmaceuticals is a privately held biopharmaceutical company based in Paris, France, focused on developing first-in-class drugs for indications with high unmet medical need, particularly heart failure.
Corteria Pharmaceuticals at a glance
Corteria Pharmaceuticals is a biotechnology company headquartered in France. Its most recent funding round, Series A, raised $69.5M in September 2023. Xcout tracks 5 named people at Corteria Pharmaceuticals, including Philip Janiak (CEO).
Corteria Pharmaceuticals leadership
- Philip JaniakCEO
- Stéphane Durant des AulnoisCFO
- Francesca C. LawsonCMO
- Marie-Laure OzouxCSO
- Régis OlivierCAO
Corteria Pharmaceuticals funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $69.5M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Corteria Pharmaceuticals competitors
Ranked by semantic similarity — how close each company is to Corteria Pharmaceuticals by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Imbria Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, focused on developing novel cardiovascular therapies.
BioTech
Acticor Biotech is a clinical-stage biopharmaceutical company headquartered in Paris, France, that specializes in developing innovative treatments for acute thrombotic diseases.
Similar biotechnology company
Cardior Pharmaceuticals GmbH is a clinical-stage biopharmaceutical company headquartered in Hannover, Germany. Established in 2016, the company focuses on discovering and developing RNA-based therapeutics for the prevention and treatment of heart diseases.
Biotech
Nuevocor is a biotechnology research company with its headquarters located in Singapore and additional operations in the United States and France. The company focuses on developing breakthrough gene therapies to treat untreatable cardiomyopathies.
Similar biotechnology company
Certa Therapeutics is a private biotechnology company headquartered in Melbourne, Australia, focused on developing innovative precision therapies for the treatment of fibrotic diseases.
Similar biotechnology company
Edgewise Therapeutics is a biopharmaceutical company that develops novel therapeutics for individuals facing serious cardiovascular diseases, such as hypertrophic cardiomyopathy and heart failure. The company focuses on muscle science and precision therapies to address unmet medical needs in patients and families.
Similar biotechnology company
Pathios Therapeutics Limited is a biotech company established in 2017 and registered in England and Wales, focusing on the discovery and development of first-in-class therapies.
Life Sciences
Crystalys Therapeutics is a biotechnology research company headquartered in San Diego, California, dedicated to developing novel therapies to address significant unmet medical needs.
Similar biotechnology company
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
Similar biotechnology company
Phlox Therapeutics is a private biotechnology company pioneering RNA-based gene therapies to alleviate and cure severe genetic heart diseases and cardiomyopathies. Headquartered in Naarden, Netherlands, the company focuses on innovative cardiovascular treatments.
Biotech
Qubit Pharmaceuticals is a privately held company headquartered in Paris, France, that brings precision to drug discovery and design by utilizing cutting-edge quantum physics-based science to develop life-changing treatments.
Similar biotechnology company
Coave Therapeutics is a clinical-stage biotechnology company headquartered in Paris, France. The company focuses on developing life-changing gene therapies targeting rare ocular and central nervous system diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Corteria Pharmaceuticals and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Corteria Pharmaceuticalsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →